|
CA1273336A
(en)
|
1986-04-25 |
1990-08-28 |
Chi-Ping Tseng |
Herbicidal heterocyclic carbonyl sulfonamides
|
|
US4838925A
(en)
|
1986-04-25 |
1989-06-13 |
E. I. Du Pont De Nemours And Company |
Heterocyclic acyl sulfonamides
|
|
EP1669071B1
(en)
|
1999-05-21 |
2009-07-22 |
Bristol-Myers Squibb Company |
Pyrrolotriazine inhibitors of kinases
|
|
US6982265B1
(en)
|
1999-05-21 |
2006-01-03 |
Bristol Myers Squibb Company |
Pyrrolotriazine inhibitors of kinases
|
|
JP4649046B2
(ja)
|
1999-05-21 |
2011-03-09 |
ブリストル−マイヤーズ スクイブ カンパニー |
キナーゼのピロロトリアジン阻害剤
|
|
US6770666B2
(en)
|
1999-12-27 |
2004-08-03 |
Japan Tobacco Inc. |
Fused-ring compounds and use thereof as drugs
|
|
GEP20063915B
(en)
|
2000-11-17 |
2006-09-11 |
Bristol Myers Squibb Co |
PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS AND USE THEREOF FOR TREATING p38 KINASE-ASSOCIATED CONDITIONS
|
|
US6670357B2
(en)
|
2000-11-17 |
2003-12-30 |
Bristol-Myers Squibb Company |
Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
|
|
US6867300B2
(en)
|
2000-11-17 |
2005-03-15 |
Bristol-Myers Squibb Company |
Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
|
|
AR035543A1
(es)
|
2001-06-26 |
2004-06-16 |
Japan Tobacco Inc |
Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
|
|
TWI329112B
(en)
*
|
2002-07-19 |
2010-08-21 |
Bristol Myers Squibb Co |
Novel inhibitors of kinases
|
|
US7306631B2
(en)
|
2004-03-30 |
2007-12-11 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
|
TW200613306A
(en)
*
|
2004-07-20 |
2006-05-01 |
Osi Pharm Inc |
Imidazotriazines as protein kinase inhibitors
|
|
EP1812439B2
(en)
|
2004-10-15 |
2017-12-06 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
EP1674467A1
(en)
|
2004-12-22 |
2006-06-28 |
4Sc Ag |
2,5- and 2,6-disubstituted benzazole derivatives useful as protein kinase inhibitors
|
|
US7576090B2
(en)
|
2004-12-27 |
2009-08-18 |
4Sc Ag |
Benzazole analogues and uses thereof
|
|
US7880004B2
(en)
|
2005-09-15 |
2011-02-01 |
Bristol-Myers Squibb Company |
Met kinase inhibitors
|
|
HRP20140688T1
(hr)
|
2006-07-07 |
2014-10-24 |
Bristol-Myers Squibb Company |
Inhibitori piroltriazin kinaze
|
|
US7531539B2
(en)
*
|
2006-08-09 |
2009-05-12 |
Bristol-Myers Squibb Company |
Pyrrolotriazine kinase inhibitors
|
|
WO2008021859A1
(en)
*
|
2006-08-09 |
2008-02-21 |
Bristol-Myers Squibb Company |
Pyrrolotriazine kinase inhibitors
|
|
WO2008057402A2
(en)
|
2006-11-02 |
2008-05-15 |
Cytovia, Inc. |
N-aryl-isoxazolopyrimidin-4-amines and related compounds as activators of caspases and inducers of apoptosis and the use thereof
|
|
EP2134716A1
(en)
|
2007-04-18 |
2009-12-23 |
Bristol-Myers Squibb Company |
Pyrrolotriazine kinase inhibitors
|
|
JP2011513419A
(ja)
|
2008-03-06 |
2011-04-28 |
ブリストル−マイヤーズ スクイブ カンパニー |
ピロロトリアジンキナーゼ阻害剤
|
|
WO2010002472A1
(en)
|
2008-07-02 |
2010-01-07 |
Ambit Biosciences Corporation |
Jak kinase modulating compounds and methods of use thereof
|
|
CA2738429C
(en)
|
2008-09-26 |
2016-10-25 |
Intellikine, Inc. |
Heterocyclic kinase inhibitors
|
|
CN102245610B
(zh)
|
2008-10-08 |
2014-04-30 |
百时美施贵宝公司 |
吡咯并三嗪激酶抑制剂
|
|
US20100204265A1
(en)
|
2009-02-09 |
2010-08-12 |
Genelabs Technologies, Inc. |
Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections
|
|
US7973013B2
(en)
|
2009-09-21 |
2011-07-05 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
|
US8455451B2
(en)
|
2009-09-21 |
2013-06-04 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
|
WO2011058109A1
(en)
|
2009-11-12 |
2011-05-19 |
Ucb Pharma S.A. |
Fused bicyclic pyrrole and imidazole derivatives as kinase inhibitors
|
|
US9073927B2
(en)
|
2010-01-22 |
2015-07-07 |
Fundacion Centro Nacional De Investigaciones Oncologicas Carlos Iii |
Inhibitors of PI3 kinase
|
|
WO2011141713A1
(en)
|
2010-05-13 |
2011-11-17 |
Centro Nacional De Investigaciones Oncologicas (Cnio) |
New bicyclic compounds as pi3-k and mtor inhibitors
|
|
AU2011282241B2
(en)
|
2010-07-19 |
2015-07-30 |
Gilead Sciences, Inc. |
Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
|
|
BR112013008017A2
(pt)
|
2010-09-20 |
2016-06-14 |
Gilead Sciences Inc |
análogos de carba-nucleosídeo 2-flúor substituídos para tratamento antiviral
|
|
AU2013257018B2
(en)
|
2012-05-04 |
2017-02-16 |
Merck Patent Gmbh |
Pyrrolotriazinone derivatives
|
|
US9724352B2
(en)
|
2012-05-31 |
2017-08-08 |
Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences |
Pyrrolo[2,1-F[1,2,4]triazine compounds, preparation methods and applications thereof
|
|
CN102675323B
(zh)
|
2012-06-01 |
2014-04-09 |
南京药石药物研发有限公司 |
吡咯并[2,1-f][1,2,4]三嗪衍生物及其抗肿瘤用途
|
|
EP2865671B1
(en)
|
2012-06-22 |
2017-11-01 |
Sumitomo Chemical Company, Ltd |
Fused heterocyclic compound
|
|
WO2014015523A1
(en)
|
2012-07-27 |
2014-01-30 |
Hutchison Medipharma Limited |
Novel heteroaryl and heterocycle compounds, compositions and methods
|
|
EP2938610A2
(en)
|
2012-12-28 |
2015-11-04 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Inhibitors of the usp1/uaf1 deubiquitinase complex and uses thereof
|
|
US9050345B2
(en)
|
2013-03-11 |
2015-06-09 |
Bristol-Myers Squibb Company |
Pyrrolotriazines as potassium ion channel inhibitors
|
|
US20160089371A1
(en)
|
2013-03-15 |
2016-03-31 |
Intellikine, Llc |
Combination of Kinase Inhibitors and Uses Thereof
|
|
WO2015066371A1
(en)
|
2013-10-31 |
2015-05-07 |
Forum Pharmaceuticals, Inc. |
SPIRO-OXADIAZOLINE COMPOUNDS AS AGONISTS OF α-7-NICOTINIC ACETYLCHOLINE RECEPTORS
|
|
WO2015126808A2
(en)
|
2014-02-18 |
2015-08-27 |
Baldwin John J |
Hbv assay
|
|
CN104974163B
(zh)
|
2014-04-14 |
2017-11-07 |
广东东阳光药业有限公司 |
取代的杂芳基化合物及其组合物和用途
|
|
WO2016040764A1
(en)
|
2014-09-12 |
2016-03-17 |
Spero Therapeutics, Inc. |
Carbonyl linked bicyclic heteroaryl n-benzimidazoles and analogs as antibiotic tolerance inhibitors
|
|
WO2016119707A1
(en)
|
2015-01-29 |
2016-08-04 |
Hutchison Medipharma Limited |
Novel heteroaryl and heterocycle compounds, compositions and methods
|
|
WO2016190847A1
(en)
|
2015-05-26 |
2016-12-01 |
Calitor Sciences, Llc |
Substituted heteroaryl compounds and methods of use
|
|
WO2017004134A1
(en)
|
2015-06-29 |
2017-01-05 |
Nimbus Iris, Inc. |
Irak inhibitors and uses thereof
|
|
JP2018520201A
(ja)
*
|
2015-07-23 |
2018-07-26 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
Ｔｇｆベーター受容体アンタゴニスト
|
|
JP2018528951A
(ja)
|
2015-08-31 |
2018-10-04 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
ＴＧＦβ受容体アンタゴニスト
|
|
ES2969565T3
(es)
|
2015-09-30 |
2024-12-13 |
Max Planck Ges Zur Foerderung Derwissenschaften E V |
Derivados heteroarílicos como inhibidores de la sepiapterina reductasa
|
|
WO2017070089A1
(en)
|
2015-10-19 |
2017-04-27 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
CN105534984A
(zh)
|
2015-11-02 |
2016-05-04 |
广东中西达一新药开发有限公司 |
吡咯并三嗪类衍生物在预防或治疗乙肝病毒感染中的应用
|
|
CN105669680B
(zh)
|
2016-03-24 |
2018-02-23 |
南京药捷安康生物科技有限公司 |
吡咯并[2,1‑f][1,2,4]三嗪‑4(1H)‑酮衍生物类PDE9A抑制剂
|
|
KR102587382B1
(ko)
|
2016-04-29 |
2023-10-12 |
솔루스첨단소재 주식회사 |
유기 발광 화합물 및 이를 이용한 유기 전계 발광 소자
|
|
KR102288246B1
(ko)
|
2016-06-25 |
2021-08-10 |
수조우 킨터 제약회사(주) |
라파마이신 신호전달 경로 저해제의 기계적 표적 및 이의 치료학적 적용
|
|
AU2017295863B2
(en)
|
2016-07-13 |
2022-07-07 |
Medic Life Sciences, Inc. |
Inhibitors of cyclin-dependent kinase 7 (CDK7)
|
|
US20220041607A1
(en)
|
2016-08-17 |
2022-02-10 |
Shenzhen Targetrx, Inc. |
Fused bicyclic compound for inhibiting activity of tyrosine kinase
|
|
CN108276463A
(zh)
|
2017-01-06 |
2018-07-13 |
米文君 |
一类新的化合物及其用途
|
|
CN108341819B
(zh)
|
2017-01-22 |
2021-06-15 |
南京药捷安康生物科技有限公司 |
磷酸二酯酶抑制剂及其用途
|
|
MX2019012431A
(es)
|
2017-04-21 |
2020-08-03 |
Ikena Oncology Inc |
Inhibidores del receptor de hidrocarburos de arilo (ahr) de indol y usos de los mismos.
|
|
AR112027A1
(es)
|
2017-06-15 |
2019-09-11 |
Biocryst Pharm Inc |
Inhibidores de alk 2 quinasa que contienen imidazol
|
|
CN109111447A
(zh)
|
2017-06-23 |
2019-01-01 |
中国科学院上海药物研究所 |
7-位取代吡咯并三嗪类化合物或其药学上可用的盐，及其制备方法和用途
|
|
JP7311228B2
(ja)
|
2017-06-30 |
2023-07-19 |
ベイジン タイド ファーマシューティカル カンパニー リミテッド |
Ｒｈｏ－関連プロテインキナーゼ阻害剤、それを含む医薬組成物並びにその調製方法及び使用
|
|
WO2019027765A1
(en)
|
2017-08-02 |
2019-02-07 |
Northwestern University |
SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS AND USES THEREOF
|
|
US20220054496A1
(en)
|
2018-09-13 |
2022-02-24 |
Fundación Del Sector Público Estatal Centro Nacional De Investigaciones Oncologicas Carlos III (F.S. |
Modulation of trf1 for brain cancer treatment
|
|
EP3867253A4
(en)
|
2018-10-16 |
2022-05-18 |
Ikena Oncology, Inc. |
Indole ahr inhibitors and uses thereof
|
|
AU2019387491A1
(en)
|
2018-11-30 |
2021-05-27 |
Celularity Inc. |
Expansion of natural killer cells and ILC3 cells with novel aromatic compounds
|
|
JP2022511457A
(ja)
|
2018-11-30 |
2022-01-31 |
セルラリティ インク． |
造血幹細胞および前駆細胞の活性化に使用するための芳香族化合物
|
|
WO2020119592A1
(zh)
|
2018-12-12 |
2020-06-18 |
信达生物制药(苏州)有限公司 |
一种新颖的三并环结构化合物及其制备方法和用途
|
|
CN112771048B
(zh)
|
2018-12-19 |
2022-08-19 |
南京药石科技股份有限公司 |
流感病毒复制抑制剂及其中间体和用途
|
|
US12391705B2
(en)
|
2018-12-19 |
2025-08-19 |
Shy Therapeutics, Llc |
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
|
|
MX2021010319A
(es)
|
2019-03-01 |
2021-12-10 |
Revolution Medicines Inc |
Compuestos biciclicos de heteroarilo y usos de estos.
|
|
US11760752B2
(en)
|
2019-03-21 |
2023-09-19 |
University Of Maryland, Baltimore |
Carboxylic acid, acyl sulfonamide and acyl sulfamide-derivatized bicyclic aza-heteroaromatics as selective Mcl-1 inhibitors and as dual Mcl-1/Bcl-2 inhibitors
|
|
CN111825675B
(zh)
|
2019-04-15 |
2023-08-01 |
武汉朗来科技发展有限公司 |
Rock抑制剂及其制备方法和用途
|
|
WO2020210970A1
(en)
|
2019-04-16 |
2020-10-22 |
Bioardis Llc |
Imidazotriazine derivatives as cd73 inhibitors
|
|
CN112142744A
(zh)
|
2019-06-28 |
2020-12-29 |
上海瑛派药业有限公司 |
取代的稠合杂芳双环化合物作为激酶抑制剂及其应用
|
|
JP7557522B2
(ja)
|
2019-07-16 |
2024-09-27 |
オリック ファーマシューティカルズ，インク． |
Ｃｄ７３阻害剤
|
|
WO2021055747A1
(en)
|
2019-09-19 |
2021-03-25 |
Totus Medicines Inc. |
Therapeutic conjugates
|
|
PY2062527A
(es)
|
2019-10-09 |
2021-09-23 |
Biocryst Pharm Inc |
Inhibidores del factor d del complemento para administración oral
|
|
WO2021094209A1
(en)
|
2019-11-12 |
2021-05-20 |
Bayer Aktiengesellschaft |
Substituted pyrrolo triazine carboxamide derivatives as prostaglandin ep3 receptor antagonists
|
|
WO2021097299A1
(en)
|
2019-11-14 |
2021-05-20 |
Behavioral Diagnostics, Llc |
Methods and compositions for smoking cessation
|
|
PH12022551513A1
(en)
*
|
2019-12-20 |
2023-04-24 |
Mirati Therapeutics Inc |
Sos1 inhibitors
|
|
JP2023513047A
(ja)
|
2020-01-30 |
2023-03-30 |
シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト |
殺有害生物的に有効な縮合二環式芳香族複素環式アミノ化合物
|
|
WO2021194927A1
(en)
|
2020-03-22 |
2021-09-30 |
Tlc Biopharmaceuticals, Inc. |
Composition of antiviral agent for use in prophylactic or post-exposure treatment of infectious or respiratory diseases
|
|
TW202204339A
(zh)
*
|
2020-03-31 |
2022-02-01 |
美商施萬生物製藥研發 Ip有限責任公司 |
經取代的嘧啶及使用方法
|
|
WO2021222807A1
(en)
|
2020-04-30 |
2021-11-04 |
Ajk Pharmaceutical Llc |
Fatty acyl and fatty ether conjugates of remdesivir and its active metabolites as antivirals
|
|
WO2022007966A1
(zh)
*
|
2020-07-10 |
2022-01-13 |
四川海思科制药有限公司 |
Pb2抑制剂及其制备方法和用途
|
|
CN114105989A
(zh)
|
2020-08-31 |
2022-03-01 |
中国科学院大连化学物理研究所 |
一种碘代吡咯并三嗪胺类化合物的制备方法和应用
|
|
CL2020003441A1
(es)
*
|
2020-12-30 |
2021-04-30 |
Univ Tecnica Federico Santa Maria Utfsm |
Convertidor de potencia parcial dc-dc de topología controlable
|
|
WO2023027948A1
(en)
|
2021-08-21 |
2023-03-02 |
Relay Therapeutics, Inc. |
Jak2 inhibitors and methods of use thereof
|
|
WO2023110843A1
(en)
|
2021-12-15 |
2023-06-22 |
Almirall, S.A. |
Heterobicyclic derivatives as itk inhibitors
|
|
WO2023116865A1
(zh)
|
2021-12-23 |
2023-06-29 |
优领医药科技（上海）有限公司 |
含吡唑类衍生物、其药学上可接受的盐及其制备方法和应用
|
|
WO2023160572A1
(zh)
|
2022-02-24 |
2023-08-31 |
楚浦创制（武汉）医药科技有限公司 |
吡唑类衍生物、药物组合物及应用
|